Table of contents
November 2004 Vol 3 No 11
In this issue
p895 | doi:10.1038/nrd1566
Editorial: The time is coming
p897 | doi:10.1038/nrd1567
News and Analysis
News
Vioxx risk could signify trouble in class
p899 | doi:10.1038/nrd1560
News
Better antibiotics through chemistry
p900 | doi:10.1038/nrd1574
News in Brief
Good news for malaria vaccine... | ...but bad news for flu vaccine | Parkinson's trial halted | Nobel Prizes announced | Dogs sniff out cancer
p901 | doi:10.1038/nrd1575
Patent watch
No adverse inference for failure to obtain or disclose opinion
p902 | doi:10.1038/nrd1557
Patent watch
Federal Circuit law trumps regional circuit law
p902 | doi:10.1038/nrd1571
Patent watch
Infringement reversed in AstraZeneca versus Mutual
p902 | doi:10.1038/nrd1572
Patent primer
Oppositions and Appeals at the EPO
p903 | doi:10.1038/nrd1556
An Audience With
Janet Woodcock discusses the role of the FDA in improving pharma productivity
p904 | doi:10.1038/nrd1570
From the analyst's couch
Apoptosis-targeting therapies
p905 | doi:10.1038/nrd1554
Fresh from the Pipeline
Duloxetine hydrochloride
p907 | doi:10.1038/nrd1564
Research Highlights
Rheumatoid arthritis: Halting disease in its tracks
p909 | doi:10.1038/nrd1561
Drug delivery: Carbs deliver the goods
p910 | doi:10.1038/nrd1558
Computational chemistry: Flexible approach to drug design
p910 | doi:10.1038/nrd1562
Screening: Screen if you want to go faster!
p911 | doi:10.1038/nrd1569
In brief
Cancer | Antibacterials | Chemical genetics | Diabetes
p912 | doi:10.1038/nrd1559
Structural biology: Crystallizing the changes
p912 | doi:10.1038/nrd1563
Focus on: Atherothrombosis
Reviews
Molecular, cellular and functional imaging of atherothrombosis
Robin P. Choudhury, Valentin Fuster & Zahi A. Fayad
p913 | doi:10.1038/nrd1548
Reviews
Molecular, cellular and functional imaging of atherothrombosis
Robin P. Choudhury, Valentin Fuster & Zahi A. Fayad
p913 | doi:10.1038/nrd1548
Drugs as materials: valuing physical form in drug discovery
Colin R. Gardner, Christopher T. Walsh & Örn Almarsson
p926 | doi:10.1038/nrd1550
Docking and scoring in virtual screening for drug discovery: methods and applications
Douglas B. Kitchen, Hélène Decornez, John R. Furr & Jürgen Bajorath
p935 | doi:10.1038/nrd1549
Principles for modulation of the nuclear receptor superfamily
Hinrich Gronemeyer, Jan-Åke Gustafsson & Vincent Laudet
p950 | doi:10.1038/nrd1551
Functional genomics to new drug targets
Richard Kramer & Dalia Cohen
p965 | doi:10.1038/nrd1552
Perspective
Opinion
Stopping clinical trials by design
John Whitehead
p973 | doi:10.1038/nrd1553
Careers and Recruitment
Flexible working attracts women to industry
Joanna Owens
p981 | doi:10.1038/nrd1568
Correspondence
Correspondence: Properties of ApoA-I Milano
Patrick Linsel-Nitschke & Alan R. Tall
| doi:10.1038/nrd1554-c2
